Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) Invested Capital (2016 - 2025)

Kiora Pharmaceuticals' Invested Capital history spans 11 years, with the latest figure at $16.1 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 37.4% year-over-year to $16.1 million; the TTM value through Dec 2025 reached $16.1 million, down 37.4%, while the annual FY2025 figure was $16.1 million, 37.4% down from the prior year.
  • Invested Capital reached $16.1 million in Q4 2025 per KPRX's latest filing, down from $22.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $34.9 million in Q1 2024 to a low of -$59870.0 in Q3 2021.
  • Average Invested Capital over 5 years is $17.0 million, with a median of $14.6 million recorded in 2021.
  • Peak YoY movement for Invested Capital: crashed 101.0% in 2021, then soared 18197.8% in 2022.
  • A 5-year view of Invested Capital shows it stood at $14.6 million in 2021, then dropped by 25.68% to $10.8 million in 2022, then tumbled by 43.61% to $6.1 million in 2023, then skyrocketed by 321.62% to $25.8 million in 2024, then crashed by 37.4% to $16.1 million in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Invested Capital are $16.1 million (Q4 2025), $22.4 million (Q3 2025), and $22.1 million (Q2 2025).